Perfluorooctanoate and perfluorooctanesulfonate plasma concentrations are not associated with the risk of prostate, bladder, pancreatic, or liver cancer. according to new research.
Perfluorooctanoate and perfluorooctanesulfonate plasma concentrations are not associated with the risk of prostate, bladder, pancreatic, or liver cancer. according to new research.